Global Innovative Platforms Inc. (GIPL)

OTCMKTS · Delayed Price · Currency is USD
0.5100
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST
Market Cap23.84M +12,394.6%
Revenue (ttm)n/a
Net Income-718.25K
EPS-0.02
Shares Out46.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume463
Open0.5100
Previous Close0.5100
Day's Range0.5100 - 0.5100
52-Week Range0.1100 - 2.9000
Beta8,118.74
RSI43.42
Earnings DateFeb 6, 2026

About GIPL

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was ... [Read more]

Sector Financials
Founded 2020
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol GIPL
Full Company Profile

News

Global Innovative Platforms Announces Completion of First Phase of Breath Test Study for Early Heartworm Detection

New non-invasive diagnostic may identify heartworm months earlier than current methods New non-invasive diagnostic may identify heartworm months earlier than current methods

4 months ago - GlobeNewsWire